Works matching AU Jun Ho Yi

Results: 50
    1
    2
    3
    4
    5

    Current Treatment Patterns and the Role of Upfront Autologous Stem Cell Transplantation in Patients with Peripheral T-Cell Lymphoma: A Korean Nationwide, Multicenter Prospective Registry Study (CISL 1404).

    Published in:
    Cancer Research & Treatment, 2023, v. 55, n. 2, p. 684, doi. 10.4143/crt.2022.1434
    By:
    • Hyungwoo Cho;
    • Dok Hyun Yoon;
    • Dong-Yeop Shin;
    • Youngil Koh;
    • Sung-Soo Yoon;
    • Seok Jin Kim;
    • Young Rok Do;
    • Gyeong-Won Lee;
    • Jae-Yong Kwak;
    • Yong Park;
    • Min Kyoung Kim;
    • Hye Jin Kang;
    • Jun Ho Yi;
    • Kwai Han Yoo;
    • Won Sik Lee;
    • Byeong Bae Park;
    • Jae Cheol Jo;
    • Hyeon-Seok Eom;
    • Hyo Jung Kim;
    • Seong Hyun Jeong
    Publication type:
    Article
    6
    7

    Pegfilgrastim Prophylaxis Is Effective in the Prevention of Febrile Neutropenia and Reduces Mortality in Patients Aged ≥ 75 Years with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: A Prospective Cohort Study.

    Published in:
    Cancer Research & Treatment, 2022, v. 54, n. 4, p. 1268, doi. 10.4143/crt.2021.1168
    By:
    • Seong Hyun Jeong;
    • Seok Jin Kim;
    • Dok Hyun Yoon;
    • Yong Park;
    • Hye Jin Kang;
    • Youngil Koh;
    • Gyeong-Won Lee;
    • Won-Sik Lee;
    • Deok-Hwan Yang;
    • Young Rok Do;
    • Min Kyoung Kim;
    • Kwai Han Yoo;
    • Yoon Seok Choi;
    • Hwan Jung Yun;
    • Jun Ho Yi;
    • Jae-Cheol Jo;
    • Hyeon-Seok Eom;
    • Jae-Yong Kwak;
    • Ho-Jin Shin;
    • Byeong Bae Park
    Publication type:
    Article
    8

    Multicenter Retrospective Analysis of Clinical Characteristics, Treatment Patterns, and Outcomes in Very Elderly Patients with Diffuse Large B-Cell Lymphoma: The Korean Cancer Study Group LY16-01.

    Published in:
    Cancer Research & Treatment, 2018, v. 50, n. 2, p. 590, doi. 10.4143/crt.2017.172
    By:
    • Jung Hye Choi;
    • Tae Min Kim;
    • Hyo Jung Kim;
    • Sung Ae Koh;
    • Yeung-Chul Mun;
    • Hye Jin Kang;
    • Yun Hwa Jung;
    • Hyeok Shim;
    • So Young Chong;
    • Der-Sheng Sun;
    • Soonil Lee;
    • Byeong Bae Park;
    • Jung Hye Kwon;
    • Seung-Hyun Nam;
    • Jun Ho Yi;
    • Young Jin Yuh;
    • Jong-Youl Jin;
    • Jae Joon Han;
    • Seok-Hyun Kim
    Publication type:
    Article
    9

    A Retrospective Analysis for Patients with HER2-Positive Gastric Cancer Who Were Treated with Trastuzumab-Based Chemotherapy: In the Perspectives of Ethnicity and Histology.

    Published in:
    Cancer Research & Treatment, 2016, v. 48, n. 2, p. 553, doi. 10.4143/crt.2015.155
    By:
    • Jun Ho Yi;
    • Jung Hun Kang;
    • In Gyu Hwang;
    • Hee Kyung Ahn;
    • Hyun Jin Baek;
    • Soon Il Lee;
    • Do Hyoung Lim;
    • Young-Woong Won;
    • Jun Ho Ji;
    • Hyo Song Kim;
    • Sun Young Rha;
    • Sung Yong Oh;
    • Kyung Eun Lee;
    • Taekyu Lim;
    • Chi Hoon Maeng;
    • Moon Jin Kim;
    • Seung Tae Kim;
    • Jeeyun Lee;
    • Joon Oh Park;
    • Young Suk Park
    Publication type:
    Article
    10

    Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial.

    Published in:
    Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-47198-4
    By:
    • Changhee Park;
    • Ho Sup Lee;
    • Ka-Won Kang;
    • Won-Sik Lee;
    • Young Rok Do;
    • Jae-Yong Kwak;
    • Ho-Jin Shin;
    • Sung-Yong Kim;
    • Jun Ho Yi;
    • Sung-Nam Lim;
    • Jeong-Ok Lee;
    • Deok-Hwan Yang;
    • Hun Jang;
    • Byoungsan Choi;
    • Jiwoo Lim;
    • Choong Hyun Sun;
    • Ja Min Byun;
    • Sung-Soo Yoon;
    • Youngil Koh
    Publication type:
    Article
    11
    12
    13
    14

    Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and <sup>18</sup>F-FDG PET/CT.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 12, p. 1, doi. 10.1038/s41408-021-00577-2
    By:
    • Cho, Hee Jeong;
    • Jung, Sung-Hoon;
    • Jo, Jae-Cheol;
    • Lee, Yoo Jin;
    • Yoon, Sang Eun;
    • Park, Sung-Soo;
    • Kim, Do Young;
    • Shin, Ho-Jin;
    • Mun, Yeung-Chul;
    • Yi, Jun Ho;
    • Kim, Hyo Jung;
    • Kim, Da Jung;
    • Lee, Ho Sup;
    • Bae, Sung Hwa;
    • Hong, Chae Moon;
    • Jeong, Shin Young;
    • Min, Jung-Joon;
    • Sohn, Sang Kyun;
    • Min, Chang-Ki;
    • Kim, Kihyun
    Publication type:
    Article
    15

    Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantation.

    Published in:
    Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.1230629
    By:
    • Seok Jin Kim;
    • Jae-Cheol Jo;
    • Dok Hyun Yoon;
    • Deok-Hwan Yang;
    • Sang Eun Yoon;
    • Gyeong-Won Lee;
    • Jee Hyun Kong;
    • Yong Park;
    • Ka-Won Kang;
    • Ho-Sup Lee;
    • Sung Yong Oh;
    • Ho-Jin Shin;
    • Won Sik Lee;
    • Yoon Seok Choi;
    • Seong Hyun Jeong;
    • Min Kyoung Kim;
    • Hye Jin Kang;
    • Jun Ho Yi;
    • Sung-Nam Lim;
    • Ho-Young Yhim
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27

    PD167 Charting A Sustainable Way To Subsidize Implants In Singapore.

    Published in:
    2025
    By:
    • Soon, Swee Sung;
    • Ding, Wayne;
    • Ee Wong, Yen;
    • Ho, Yan Teck;
    • Ooi, Lydia;
    • See-Toh, Rachel;
    • PM Batcagan-Abueg, Ada;
    • Yi Ho, Jun;
    • Low, Foo Eng;
    • Unni, Bindhu;
    • Gan, Hua Pey;
    • Ye Yeo, Chong;
    • Heng, Jeshuan;
    • Chew, Sarah;
    • Lim, Qinyi;
    • Lim, Elysia;
    • Ng, Zhen Long;
    • Ng, Jaryl;
    • Ju, Hong;
    • Ng, Kwong
    Publication type:
    Abstract
    28
    29
    30
    31
    32
    33
    34
    35

    Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015).

    Published in:
    Annals of Hematology, 2023, v. 102, n. 8, p. 2233, doi. 10.1007/s00277-023-05308-0
    By:
    • Kim, Mihee;
    • Lee, Je-Jung;
    • Min, Chang-Ki;
    • Lee, Ji Yun;
    • Jo, Jae-Cheol;
    • Yoon, Sung-Soo;
    • Lim, Sung-Nam;
    • Do, Young Rok;
    • Kim, Kihyun;
    • Lee, Jae Hoon;
    • Yoo, Kwai Han;
    • Bae, Sung Hwa;
    • Yi, Jun Ho;
    • Jung, Jongheon;
    • Eom, Hyeon-Seok;
    • Jung, Sung-Hoon
    Publication type:
    Article
    36

    A non-interventional, post-marketing surveillance study evaluating the safety and effectiveness of biosimilar rituximab (CT-P10) during routine clinical practice in the Republic of Korea.

    Published in:
    Expert Opinion on Biological Therapy, 2023, v. 23, n. 8, p. 737, doi. 10.1080/14712598.2023.2177101
    By:
    • Jo, Jae-Cheol;
    • Jeon, Youngwoo;
    • Kim, DaJung;
    • Yang, Deok-Hwan;
    • Lee, Won Sik;
    • Choi, Yoon Seok;
    • Yi, Jun Ho;
    • Yoon, Dok Hyun;
    • Kong, Jee Hyun;
    • Choe, Jung-Yoon;
    • Kim, SungHyun;
    • Ahn, KeumYoung;
    • Park, TaeHong;
    • Ju, Hana;
    • Kwon, Soonbum;
    • Cho, Seok-Goo
    Publication type:
    Article
    37
    38

    Real‐world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis.

    Published in:
    Cancer Communications, 2021, v. 41, n. 3, p. 275, doi. 10.1002/cac2.12150
    By:
    • Yi, Jun Ho;
    • Kim, Seok Jin;
    • Yoon, Dok Hyun;
    • Suh, Cheolwon;
    • Chang, Myung Hee;
    • Yang, Deok Hwan;
    • Jo, Jae‐Cheol;
    • Hyun, Shin Young;
    • Eom, Hyeon‐Seok;
    • Lee, Jeong‐Ok;
    • Kwon, Ji Hyun;
    • Han, Sang Hoon;
    • Lee, Seung‐Shin;
    • Kwak, Jae‐Yong;
    • Kim, Se Hyung;
    • Kim, Dae Sik;
    • Lee, Ji Hyun;
    • Oh, Sung Yong;
    • Ryoo, Hun Mo;
    • Kim, Hyo Jung
    Publication type:
    Article
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50